- Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
-
Kapoor S
- KMID: 2316723
- Radiat Oncol J.
- 2012 Dec;30(4):226-227.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus
-
Kim DL
- KMID: 2222462
- Korean Diabetes J.
- 2008 Dec;32(6):532-533.
- doi: 10.4093/kdj.2008.32.6.532
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
-
Li S, Tian H
- KMID: 2280746
- Diabetes Metab J.
- 2013 Feb;37(1):81-82.
- doi: 10.4093/dmj.2013.37.1.81
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
-
Kim SY
- KMID: 2174372
- Diabetes Metab J.
- 2012 Dec;36(6):460-461.
- doi: 10.4093/dmj.2012.36.6.460
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats (Korean Diabetes J 2010;34:191-9)
-
Kim ES
- KMID: 2029881
- Korean Diabetes J.
- 2010 Aug;34(4):263-264.
- doi: 10.4093/kdj.2010.34.4.263
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
-
Kim KJ, Song SO, Lee BW
- KMID: 2280747
- Diabetes Metab J.
- 2013 Feb;37(1):83-84.
- doi: 10.4093/dmj.2013.37.1.83
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
-
Song SO, Kim KJ, Lee BW
- KMID: 2174373
- Diabetes Metab J.
- 2012 Dec;36(6):462-463.
- doi: 10.4093/dmj.2012.36.6.462
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Effects of Rosiglitazone on Inflammation in Otsuka Long-Evans Tokushima Fatty Rats (Korean Diabetes J 2010;34:191-9)
-
Yang SJ, Park CY
- KMID: 2029880
- Korean Diabetes J.
- 2010 Aug;34(4):261-262.
- doi: 10.4093/kdj.2010.34.4.261
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Insulin Resistance and Insulin Resistance Syndrome
-
Park KS
- KMID: 2168163
- Hanyang Med Rev.
- 2009 May;29(2):130-133.
Insulin resistance is the main pathophysiologic abnormality of type 2 diabetes mellitus. Insulin resistance and resultant compensatory hyperinsulinemia are closely associated with other important cardiovascular risk factors such as hypertension,... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Oral Hypoglycemic Agents in Type 2 Diabetic Patients with Hepatic Dysfunction
-
Lee KY
- KMID: 2059849
- J Korean Diabetes.
- 2011 Dec;12(4):190-193.
- doi: 10.4093/jkd.2011.12.4.190
The prevalence of type 2 diabetes mellitus in the Korea has increased dramatically over the past decade. Clinicians can prescribe the following six currently available classes of oral hypoglycemic agents:... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
-
Ko KD, Kim KK, Lee KR
- KMID: 2387482
- J Obes Metab Syndr.
- 2017 Jun;26(2):102-106.
- doi: 10.7570/jomes.2017.26.2.102
Thiazolidinediones (TZDs) are oral anti-diabetic drugs that are peroxisome proliferator-activated receptor gamma (PPARγ) agonists and act as insulin sensitizers. The clinical efficacy and durability of the currently available TZDs in... -
- CITED
-
- Close
- SHARE
-
- Close
- Current therapeutic agents and anesthetic considerations for diabetes mellitus
-
Kang H
- KMID: 2236267
- Korean J Anesthesiol.
- 2012 Sep;63(3):195-202.
- doi: 10.4097/kjae.2012.63.3.195
As the incidence of diabetes mellitus (DM) continues to increase worldwide, more diabetic patients will be presented for surgery and anesthesia. This increase of DM is a consequence of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose-Lowering Agents in the Management of Nonalcoholic Fatty Liver Disease
-
Yang H, Park CY
- KMID: 2415852
- J Korean Diabetes.
- 2018 Jun;19(2):88-96.
- doi: 10.4093/jkd.2018.19.2.88
Nonalcoholic fatty liver disease (NAFLD) is more prevalent in diabetic patients than in non-diabetic subjects, because the two diseases share a common pathophysiological mechanism. Associated abnormalities can be observed from... -
- CITED
-
- Close
- SHARE
-
- Close
- Targeting the Peroxisome Proliferator-Activated Receptor-gamma to Counter the Inflammatory Milieu in Obesity
-
Corzo C, Griffin PR
- KMID: 2174220
- Diabetes Metab J.
- 2013 Dec;37(6):395-403.
- doi: 10.4093/dmj.2013.37.6.395
Adipose tissue, which was once viewed as a simple organ for storage of triglycerides, is now considered an important endocrine organ. Abnormal adipose tissue mass is associated with defects in... -
- CITED
-
- Close
- SHARE
-
- Close
- DPP-4 Inhibitors as a New Option for the Management of Type 2 Diabetes
-
Lee SA
- KMID: 2173921
- J Korean Diabetes.
- 2013 Sep;14(3):128-132.
- doi: 10.4093/jkd.2013.14.3.128
Dipeptidylpeptidase-4 (DPP-4) inhibitors are new glucose-lowering agents with mechanisms that differ from those of previous oral hypoglycemic agents (OHAs). DPP-4 inhibitors have shown a continuous glucose lowering effect (> 0.5%)... -
- CITED
-
- Close
- SHARE
-
- Close
- Thiazolidinediones on Insulin Resistance and Insulin Secretion in Obese Diabetic OLETF Rats
-
Noh JH, Hong SH, Lee KH, Min KM, Yang TY, Lee MS, Kim KW, Lee MK
- KMID: 2008094
- J Korean Diabetes Assoc.
- 2007 Jan;31(1):33-43.
- doi: 10.4093/jkda.2007.31.1.33
BACKGROUND: Thiazolidinediones are synthetic peroxisome proliferator-activated receptor-gamma agonists that decrease insulin resistance but, as in vitro and in vivo studies suggest, may have direct beneficial effects on pancreatic beta cells.... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
-
Ko SH
- KMID: 2458963
- J Korean Diabetes.
- 2019 Sep;20(3):142-148.
- doi: 10.4093/jkd.2019.20.3.142
For patients with newly diagnosed type 2 diabetes mellitus (T2DM), lifestyle modifications including medical nutrition therapy, weight control, physical activity, smoking cessation, and avoidance of alcohol abuse should be initiated.... -
- CITED
-
- Close
- SHARE
-
- Close
- Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus
-
Kim SW
- KMID: 2222359
- Korean Diabetes J.
- 2010 Dec;34(6):331-337.
- doi: 10.4093/kdj.2010.34.6.331
Although there is no HbA1c threshold for cardiovascular risk, the American Diabetic Association-recommended goal of HbA1c < 7.0% appears to be unacceptably high. To achieve an optimal HbA1c level goal... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Sulfonylureas on Peroxisome Proliferator-Activated Receptor gamma Activity and on Glucose Uptake by Thiazolidinediones
-
Lee KW, Ku YH, Kim M, Ahn BY, Chung SS, Park KS
- KMID: 2281640
- Diabetes Metab J.
- 2011 Aug;35(4):340-347.
- doi: 10.4093/dmj.2011.35.4.340
BACKGROUND: Sulfonylurea primarily stimulates insulin secretion by binding to its receptor on the pancreatic beta-cells. Recent studies have suggested that sulfonylureas induce insulin sensitivity through peroxisome proliferator-activated receptor gamma (PPARgamma),... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
-
Boutari C, Perakakis , Mantzoros
- KMID: 2407118
- Endocrinol Metab.
- 2018 Mar;33(1):33-43.
- doi: 10.3803/EnM.2018.33.1.33
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting 30% of the general population and 40% to 70% of obese individuals. Adipose tissue plays a crucial role in... -
- CITED
-
- Close
- SHARE
-
- Close
